Back
Oramed Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
33
ORMP
Oramed Pharmaceuticals
Last Price:
$2.38
Seasonality Move:
6.43%
Sell
19
NBY
NovaBay Pharmaceuticals
Last Price:
$0.53
Seasonality Move:
-0.66%
Sell
33
Oramed Pharmaceuticals (ORMP)
is a Sell
Is Oramed Pharmaceuticals a Buy, Sell or Hold?
-
The current Oramed Pharmaceuticals [ORMP] share price is $2.38. The Score for ORMP is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
ORMP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
ORMP Stock Price Chart
What is Oramed Pharmaceuticals's stock price today?
-
The Oramed Pharmaceuticals share price today is $2.38Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORMP is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.53The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
ORMP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 47.88 | Sell |
Chaikin Money Flow: | -83771 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.31 - 2.49) | Sell |
Bollinger Bands (100): | (2.31 - 2.45) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 39.44 | Sell |
Chaikin Money Flow: | 514099 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.53 - 0.67) | Sell |
Bollinger Bands (100): | (0.49 - 0.69) | Sell |
ORMP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.43 | Sell |
20-day SMA: | 2.43 | Sell |
50-day SMA: | 2.38 | Buy |
200-day SMA: | 2.43 | Sell |
8-day EMA: | 2.42 | Sell |
20-day EMA: | 2.42 | Sell |
50-day EMA: | 2.4 | Sell |
200-day EMA: | 2.49 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.54 | Sell |
20-day SMA: | 0.57 | Sell |
50-day SMA: | 0.63 | Sell |
200-day SMA: | 1.88 | Sell |
8-day EMA: | 0.54 | Sell |
20-day EMA: | 0.57 | Sell |
50-day EMA: | 0.64 | Sell |
200-day EMA: | 4.7 | Sell |
Oramed Pharmaceuticals Earnings Growth & ORMP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and a decrease next year of $0.43 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Oramed Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |